Recombinant Human Interferon α2a (Shenyang Sunshine)

干扰素α-2a生物类似药 (沈阳三生)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Human Interferon α2a (Shenyang Sunshine)
Drug Alias Namerecombinant interferon alpha-2a因特芬
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeoplasmsVirus Diseases
Global Approved IndicationsNeoplasmsVirus Diseases
Approved Indications in ChinaNeoplasmsVirus Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenyang Sunshine Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Sunshine Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasmsVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A